2025-521357-17-00CompletedPhase 1
To investigate the safety and efficacy of a novel investigational compound against neurological diseases such as Parkinson's disease in healthy men and women and patients with Parkinson's disease.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 11 Mar 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 68 (actual)
- First submitted
- 28 Apr 2025
- Start date
- 13 Jun 2025
- Lead sponsor
- Teitur Trophics ApS
- Diseases
- Parkinson disease
- EU CT number
- 2025-521357-17-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 68
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre for Human Drug Research | Leiden | Netherlands | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.